Cargando…

A Systematic Pan-Cancer Analysis of MEIS1 in Human Tumors as Prognostic Biomarker and Immunotherapy Target

Background: We intended to explore the potential immunological functions and prognostic value of Myeloid Ecotropic Viral Integration Site 1 (MEIS1) across 33 cancer types. Methods: The data were acquired from The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx) and Gene expression omnib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Han, Tang, Ying, Hua, Lichun, Wang, Zemin, Du, Guoping, Wang, Shuai, Lu, Shifeng, Li, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964192/ https://www.ncbi.nlm.nih.gov/pubmed/36836180 http://dx.doi.org/10.3390/jcm12041646

Ejemplares similares

IMPDH1, a prognostic biomarker and immunotherapy target that correlates with tumor immune microenvironment in pan-cancer and hepatocellular carcinoma
por: Liu, Chengdong, et al.
Publicado: (2022)

KNSTRN, a Poor Prognostic Biomarker, Affects the Tumor Immune Microenvironment and Immunotherapy Outcomes in Pan-Cancer
por: Zhang, Wanli, et al.
Publicado: (2023)

Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets
por: Zhang, Yinqi, et al.
Publicado: (2021)

MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma
por: Guan, Lei, et al.
Publicado: (2019)

Structural insights reveal the specific recognition of meiRNA by the Mei2 protein
por: Shen, Siyuan, et al.
Publicado: (2022)

Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy
por: Zhang, Jing, et al.
Publicado: (2022)

Mei : per flauto solo (1962)
por: Fukushima, Kazuo
Publicado: (1966)

N6AMT1 is a novel potential diagnostic, prognostic and immunotherapy response biomarker in pan-cancer
por: Wang, Mingqi, et al.
Publicado: (2023)

HIF1α: A Novel Biomarker with Potential Prognostic and Immunotherapy in Pan-cancer
por: Tian, Yonggang, et al.
Publicado: (2022)

Oncogenic and tumor suppressor function of MEIS and associated factors
por: GİRGİN, Birkan, et al.
Publicado: (2020)

Pan-cancer analysis of the prognostic and immunological role of GJB2: a potential target for survival and immunotherapy
por: Jia, Yuting, et al.
Publicado: (2023)

Meis homeobox 2 (MEIS2) inhibits the proliferation and promotes apoptosis of thyroid cancer cell and through the NF-κB signaling pathway
por: Wen, Xiaohui, et al.
Publicado: (2021)

Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapy
por: Louie, Bryan H., et al.
Publicado: (2022)

Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarker
por: Zhang, Chi, et al.
Publicado: (2022)

NNMT Is an Immune-Related Prognostic Biomarker That Modulates the Tumor Microenvironment in Pan-Cancer
por: Liu, Wenxiu, et al.
Publicado: (2023)

Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response
por: Wang, Dong-Rui, et al.
Publicado: (2022)

Potential value of PRKDC as a therapeutic target and prognostic biomarker in pan-cancer
por: Yang, Xiawei, et al.
Publicado: (2022)

Pan-Cancer Analysis of the Oncogenic and Prognostic Role of PKM2: A Potential Target for Survival and Immunotherapy
por: Liang, Nan, et al.
Publicado: (2023)

My mentors (Dascălii mei)
por: Bârsu, Cristian
Publicado: (2013)

Meis: New friends of Pax
por: Schulte, Dorothea
Publicado: (2014)

Pan-cancer analysis and experimental validation of DTL as a potential diagnosis, prognosis and immunotherapy biomarker
por: Tang, Yumei, et al.
Publicado: (2023)

MEIS1 in Hematopoiesis and Cancer. How MEIS1-PBX Interaction Can Be Used in Therapy
por: Blasi, Francesco, et al.
Publicado: (2021)

Pan-cancer analysis of the prognostic and immunological role of SNX29: a potential target for survival and immunotherapy
por: Xu, Chengfei, et al.
Publicado: (2023)

Advances in Polymeric Micelles: Responsive and Targeting Approaches for Cancer Immunotherapy in the Tumor Microenvironment
por: Cheng, Lichun, et al.
Publicado: (2023)

Genomic investigation of co-targeting tumor immune microenvironment and immune checkpoints in pan-cancer immunotherapy
por: Huang, Xing, et al.
Publicado: (2020)

Pan-Cancer Analysis Predicts FOXS1 as a Key Target in Prognosis and Tumor Immunotherapy
por: Liu, Yunqiang, et al.
Publicado: (2022)

AFF3 is a novel prognostic biomarker and a potential target for immunotherapy in gastric cancer
por: Zeng, Yuling, et al.
Publicado: (2022)

Regulation of the MEI-1/MEI-2 Microtubule-Severing Katanin Complex in Early Caenorhabditis elegans Development
por: Beard, Sarah M., et al.
Publicado: (2016)

Transcriptome and pan-cancer system analysis identify PM2.5-induced stanniocalcin 2 as a potential prognostic and immunological biomarker for cancers
por: Zhu, Dong, et al.
Publicado: (2023)

Pan-Cancer Analysis Revealed SRSF9 as a New Biomarker for Prognosis and Immunotherapy
por: Liu, Jinhui, et al.
Publicado: (2022)

YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Hu, Jian, et al.
Publicado: (2021)

Novel MEI1 compound heterozygous mutation in a sporadic family associated with spermatogenetic failure
por: Chen, Jie, et al.
Publicado: (2022)

How does Mei-yu precipitation respond to climate change?
por: Sun, Bo, et al.
Publicado: (2023)

Study of the dynamic expression of Meis1 in mice
por: Hai-Xia, Li, et al.
Publicado: (2013)

PTBPs: An immunomodulatory-related prognostic biomarker in pan-cancer
por: Chen, Chen, et al.
Publicado: (2022)

Cancer-testis antigen CEP55 serves as a prognostic biomarker and is correlated with immune infiltration and immunotherapy efficacy in pan-cancer
por: Xie, Xiaodong, et al.
Publicado: (2023)

First person – Mei-Fang Lin
Publicado: (2019)

MEIS1 and its potential as a cancer therapeutic target (Review)
por: Yao, Maozhong, et al.
Publicado: (2021)

CCDC137 Is a Prognostic Biomarker and Correlates With Immunosuppressive Tumor Microenvironment Based on Pan-Cancer Analysis
por: Guo, Lihao, et al.
Publicado: (2021)

DHRS7 is an immune-related prognostic biomarker of KIRC and pan-cancer
por: Tang, Sheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pbd6drh8gl6j2m67e483fa6a3o